Ryosuke Arauchi
Izumo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.
Journal: Pediatric research
Published: November 05, 2020
Low Serum Levels of Fibroblast Growth Factor 2 in Gunn Rats: A Hyperbilirubinemia Animal Model of Schizophrenic Symptoms.
Journal: CNS & neurological disorders drug targets
Published: December 10, 2019
Electroconvulsive shock restores the decreased coverage of brain blood vessels by astrocytic endfeet and ameliorates depressive-like behavior.
Journal: Journal of affective disorders
Published: February 21, 2019
Parvalbumin-positive GABAergic interneurons deficit in the hippocampus in Gunn rats: A possible hyperbilirubinemia-induced animal model of schizophrenia.
Journal: Heliyon
Published: September 28, 2018
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Journal: Clinical neuropharmacology
Published: September 21, 2018
Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test.
Journal: Brain and behavior
Published: January 05, 2018
Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat.
Journal: Journal of neuroinflammation
Published: April 21, 2016
Analysis of oxidative stress expressed by urinary level of biopyrrins and 8-hydroxydeoxyguanosine in patients with chronic schizophrenia.
Journal: Psychiatry and clinical neurosciences
Published: November 26, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026